Emmet Keeffe, Hepatitis Expert, Dead at 69

[Guest guest]

http://www.medpagetoday.com/PublicHealthPolicy/GeneralProfessionalIssues/28017?u\

tm_content= & utm_medium=email & utm_campaign=DailyHeadlines & utm_source=WC & userid=23\

283

Emmet Keeffe, Hepatitis Expert, Dead at 69

By Joyce Frieden, News Editor, MedPage Today

Published: August 12, 2011

Emmet Keeffe, MD, a noted hepatologist and past president of the American

Gastroenterological Association, died this week at 69, according to the HCV

Advocate, a website for patients with hepatitis C virus.

Keeffe, author of more than 700 articles, book chapters, and other publications,

served as chief of hepatology and medical director of the liver transplant

program at Stanford University. He was president of the American Society for

Gastrointestinal Endoscopy, and a member of the Board of Directors of the

American Liver Foundation.

Keeffe's research interests included the treatment of chronic hepatitis B and

chronic hepatitis C and the use of the hepatitis vaccine, especially in patients

with chronic liver disease, and selection and outcomes of liver transplantation,

according to the Stanford website.

He also studied the role of standard interferon, interferon alfacon-1, and

peginterferon alone or with ribavirin for the treatment of chronic hepatitis C.

Keeffe, who was board certified in internal medicine, received his BS from the

University of San Francisco and his MD degree from Creighton University. He did

his internship and residency at Oregon Health & Science University, and also

completed a fellowship there; he also completed a hepatology fellowship at the

University of California San Francisco.

" We extend our condolences to Dr. Keeffe's family, friends, colleagues, and

patients, " read a post on the HCV Advocate blog. " His death leaves a huge hole

in our community. "

[Guest guest]

http://www.medpagetoday.com/PublicHealthPolicy/GeneralProfessionalIssues/28017?u\

tm_content= & utm_medium=email & utm_campaign=DailyHeadlines & utm_source=WC & userid=23\

283

Emmet Keeffe, Hepatitis Expert, Dead at 69

By Joyce Frieden, News Editor, MedPage Today

Published: August 12, 2011

Emmet Keeffe, MD, a noted hepatologist and past president of the American

Gastroenterological Association, died this week at 69, according to the HCV

Advocate, a website for patients with hepatitis C virus.

Keeffe, author of more than 700 articles, book chapters, and other publications,

served as chief of hepatology and medical director of the liver transplant

program at Stanford University. He was president of the American Society for

Gastrointestinal Endoscopy, and a member of the Board of Directors of the

American Liver Foundation.

Keeffe's research interests included the treatment of chronic hepatitis B and

chronic hepatitis C and the use of the hepatitis vaccine, especially in patients

with chronic liver disease, and selection and outcomes of liver transplantation,

according to the Stanford website.

He also studied the role of standard interferon, interferon alfacon-1, and

peginterferon alone or with ribavirin for the treatment of chronic hepatitis C.

Keeffe, who was board certified in internal medicine, received his BS from the

University of San Francisco and his MD degree from Creighton University. He did

his internship and residency at Oregon Health & Science University, and also

completed a fellowship there; he also completed a hepatology fellowship at the

University of California San Francisco.

" We extend our condolences to Dr. Keeffe's family, friends, colleagues, and

patients, " read a post on the HCV Advocate blog. " His death leaves a huge hole

in our community. "